Skip to main content

Advertisement

Log in

Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B

  • Magnetic Resonance
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

We measured the accuracy of magnetic resonance elastography (MRE) for the detection and staging of liver fibrosis in chronic hepatitis B (CHB) and compared it with serum fibrosis markers.

Methods

Prospective comparison of MRE and routine serum fibrosis markers, namely serum alanine aminotransferase (ALT), serum aspartate aminotransferase (AST), ALT/AST ratio (AAR), AST to platelet ratio index (APRI) and prothrombin index (PI), was performed in 63 consecutive CHB patients who underwent MRE and histological confirmation of liver fibrosis within a 6-month interval. Diagnostic performance of MRE and serum markers for staging fibrosis (≥F1), significant fibrosis (≥F2), advanced fibrosis (≥F3) and cirrhosis (F4) was compared.

Results

The study group comprised 63 patients (19 female; mean age ± SD, 50 ± 11.9 years). MRE (ρ = 0.94, P < 0.0001), APRI (ρ = 0.42, P = 0.0006), PI (ρ = 0.42, P = 0.0006) and AST (ρ = 0.28, P = 0.028) results correlated significantly with fibrosis stage. MRE was significantly more accurate than serum fibrosis markers for the detection of significant fibrosis (0.99 vs. 0.55–0.73) and cirrhosis (0.98 vs. 0.53–0.77). Sensitivity, specificity, positive predictive and negative predictive values for MRE for significant fibrosis and cirrhosis were 97.4 %, 100 %, 100 % and 96 %, and 100 %, 95.2 %, 91.3 % and 100 %, respectively.

Conclusion

MRE is an accurate non-invasive technique for the detection and staging of liver fibrosis in CHB.

Key Points

• Magnetic resonance elastography is accurate for liver fibrosis detection and staging.

• MR elastography is more accurate than serum tests for staging liver fibrosis.

• MR elastography can potentially replace liver biopsy in chronic hepatitis B.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Liver EAFTSOT (2012) EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 57:167–185

    Google Scholar 

  2. Fattovich G (2003) Natural history and prognosis of hepatitis B. Semin Liver Dis 23:47–58

    Article  PubMed  Google Scholar 

  3. McMahon BJ (2004) The natural history of chronic hepatitis B virus infection. Semin Liver Dis 24:17–21

    Article  PubMed  Google Scholar 

  4. Hadziyannis SJ, Papatheodoridis GV (2006) Hepatitis B e antigen-negative chronic hepatitis B: natural history and treatment. Semin Liver Dis 26:130–141

    Article  CAS  PubMed  Google Scholar 

  5. Fattovich G, Olivari N, Pasino M, D'Onofrio M, Martone E, Donato F (2008) Long-term outcome of chronic hepatitis B in Caucasian patients: mortality after 25 years. Gut 57:84–90

    Article  CAS  PubMed  Google Scholar 

  6. Fattovich G, Stroffolini T, Zagni I, Donato F (2004) Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127:S35–S50

    Article  PubMed  Google Scholar 

  7. Bosch FX, Ribes J, Cléries R, Díaz M (2005) Epidemiology of hepatocellular carcinoma. Clin Liver Dis 9:191–211

    Article  PubMed  Google Scholar 

  8. Lok AS, McMahon BJ (2009) Chronic hepatitis B: update 2009. Hepatology 50:661–662

    Article  PubMed  Google Scholar 

  9. Dienstag JL, Goldin RD, Heathcote EJ et al (2003) Histological outcome during long-term lamivudine therapy. Gastroenterology 124:105–117

    Article  CAS  PubMed  Google Scholar 

  10. Marcellin P, Chang TT, Lim SG et al (2008) Long-term efficacy and safety of adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B. Hepatology 48:750–758

    Article  CAS  PubMed  Google Scholar 

  11. Chang TT, Liaw YF, Wu SS et al (2010) Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. Hepatology 52:886–893

    Article  CAS  PubMed  Google Scholar 

  12. Liver EAFTSOT (2009) EASL clinical practice guidelines: management of chronic hepatitis B. J Hepatol 50:227–242

    Article  Google Scholar 

  13. Castéra L, Nègre I, Samii K, Buffet C (1999) Pain experienced during percutaneous liver biopsy. Hepatology 30:1529–1530

    Article  PubMed  Google Scholar 

  14. Castera L (2011) Invasive and non-invasive methods for the assessment of fibrosis and disease progression in chronic liver disease. Best Pract Res Clin Gastroenterol 25:291–303

    Article  CAS  PubMed  Google Scholar 

  15. Piccinino F, Sagnelli E, Pasquale G, Giusti G (1986) Complications following percutaneous liver biopsy. A multicentre retrospective study on 68,276 biopsies. J Hepatol 2:165–173

    Article  CAS  PubMed  Google Scholar 

  16. Bravo AA, Sheth SG, Chopra S (2001) Liver biopsy. N Engl J Med 344:495–500

    Article  CAS  PubMed  Google Scholar 

  17. Cadranel JF, Rufat P, Degos F (2000) Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 32:477–481

    Article  CAS  PubMed  Google Scholar 

  18. Regev A, Berho M, Jeffers L et al (2002) Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97:2614–2618

    Article  PubMed  Google Scholar 

  19. Maharaj B, Maharaj R, Leary W et al (1986) Sampling variability and its influence on the diagnostic yield of percutaneous needle biopsy of the liver. Lancet 1:523–525

    Article  CAS  PubMed  Google Scholar 

  20. Wai CT, Greenson JK, Fontana RJ et al (2003) A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38:518–526

    Article  PubMed  Google Scholar 

  21. Castera L (2012) Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology 142:1293–1302, e1294

    Article  PubMed  Google Scholar 

  22. Rockey DC, Bissell DM (2006) Noninvasive measures of liver fibrosis. Hepatology 43:S113–S120

    Article  CAS  PubMed  Google Scholar 

  23. Halfon P, Bacq Y, De Muret A et al (2007) Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C. J Hepatol 46:395–402

    Article  PubMed  Google Scholar 

  24. Chan HL, Wong GL, Choi PC et al (2009) Alanine aminotransferase-based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat 16:36–44

    Article  PubMed  Google Scholar 

  25. Wong GL, Wong VW, Choi PC et al (2008) Assessment of fibrosis by transient elastography compared with liver biopsy and morphometry in chronic liver diseases. Clin Gastroenterol Hepatol 6:1027–1035

    Article  PubMed  Google Scholar 

  26. Castéra L, Foucher J, Bernard PH et al (2010) Pitfalls of liver stiffness measurement: a 5-year prospective study of 13,369 examinations. Hepatology 51:828–835

    PubMed  Google Scholar 

  27. Friedrich-Rust M, Nierhoff J, Lupsor M et al (2012) Performance of acoustic radiation force impulse imaging for the staging of liver fibrosis: a pooled meta-analysis. J Viral Hepat 19:e212–e219

    Article  CAS  PubMed  Google Scholar 

  28. Sporea I, Sirli R, Popescu A, Danilă M (2010) Acoustic radiation force impulse (ARFI)–a new modality for the evaluation of liver fibrosis. Med Ultrason 12:26–31

    PubMed  Google Scholar 

  29. Yin M, Talwalkar JA, Glaser KJ et al (2007) Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 5:1207–1213, e1202

    Article  PubMed Central  PubMed  Google Scholar 

  30. Huwart L, Sempoux C, Salameh N et al (2007) Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ratio index. Radiology 245:458–466

    Article  PubMed  Google Scholar 

  31. Huwart L, Sempoux C, Vicaut E et al (2008) Magnetic resonance elastography for the noninvasive staging of liver fibrosis. Gastroenterology 135:32–40

    Article  PubMed  Google Scholar 

  32. Rustogi R, Horowitz J, Harmath C et al (2012) Accuracy of MR elastography and anatomic MR imaging features in the diagnosis of severe hepatic fibrosis and cirrhosis. J Magn Reson Imaging 35:1356–1364

    Article  PubMed Central  PubMed  Google Scholar 

  33. Wang Y, Ganger DR, Levitsky J et al (2011) Assessment of chronic hepatitis and fibrosis: comparison of MR elastography and diffusion-weighted imaging. AJR Am J Roentgenol 196:553–561

    Article  PubMed Central  PubMed  Google Scholar 

  34. Godfrey EM, Patterson AJ, Priest AN et al (2012) A comparison of MR elastography and 31P MR spectroscopy with histological staging of liver fibrosis. Eur Radiol 22:2790–2797

    Article  PubMed  Google Scholar 

  35. Wang QB, Zhu H, Liu HL, Zhang B (2012) Performance of magnetic resonance elastography and diffusion-weighted imaging for the staging of hepatic fibrosis: a meta-analysis. Hepatology 56:239–247

    Article  PubMed  Google Scholar 

  36. Kim BH, Lee JM, Lee YJ et al (2011) MR elastography for noninvasive assessment of hepatic fibrosis: experience from a tertiary center in Asia. J Magn Reson Imaging 34:1110–1116

    Article  PubMed  Google Scholar 

  37. Ichikawa S, Motosugi U, Ichikawa T et al (2012) Magnetic resonance elastography for staging liver fibrosis in chronic hepatitis C. Magn Reson Med Sci 11:291–297

    Article  PubMed  Google Scholar 

  38. Chen J, Talwalkar JA, Yin M, Glaser KJ, Sanderson SO, Ehman RL (2011) Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 259:749–756

    Article  PubMed Central  PubMed  Google Scholar 

  39. Vizzotto L, Vertemati M, Gambacorta M, Sabatella G, Goffredi M, Minola E (2005) Computerized morphometry in liver cirrhosis: histological and immunohistochemical properties. In: Liver cirrhosis: new research. Nova Science, New York, p 97–112

  40. Yano M, Kumada H, Kage M et al (1996) The long-term pathological evolution of chronic hepatitis C. Hepatology 23:1334–1340

    Article  CAS  PubMed  Google Scholar 

  41. Kage M, Shimamatu K, Nakashima E, Kojiro M, Inoue O, Yano M (1997) Long-term evolution of fibrosis from chronic hepatitis to cirrhosis in patients with hepatitis C: morphometric analysis of repeated biopsies. Hepatology 25:1028–1031

    Article  CAS  PubMed  Google Scholar 

  42. Marcellin P, Ziol M, Bedossa P et al (2009) Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 29:242–247

    Article  PubMed  Google Scholar 

  43. Vizzotto L, Vertemati M, Gambacorta M, Sabatella G, Spina V, Minola E (2002) Analysis of histological and immunohistochemical patterns of the liver in posthepatitic and alcoholic cirrhosis by computerized morphometry. Mod Pathol 15:798–806

    Article  PubMed  Google Scholar 

  44. Bensamoun SF, Leclerc GE, Debernard L et al (2013) Cutoff values for alcoholic liver fibrosis using magnetic resonance elastography technique. Alcohol Clin Exp Res 37:811–817

    Article  CAS  PubMed  Google Scholar 

  45. Kim D, Kim WR, Talwalkar JA, Kim HJ, Ehman RL (2013) Advanced fibrosis in nonalcoholic fatty liver disease: noninvasive assessment with MR elastography. Radiology. doi:10.1148/radiol.13121193

    Google Scholar 

  46. Bohte AE, van Dussen L, Akkerman EM et al (2013) Liver fibrosis in type I Gaucher disease: magnetic resonance imaging, transient elastography and parameters of iron storage. PLoS One 8:e57507

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  47. Venkatesh SK, Yin M, Ehman RL (2013) Magnetic resonance elastography of liver: technique, analysis, and clinical applications. J Magn Res Imaging 37:544–555

    Article  Google Scholar 

  48. Bedossa P, Poynard T (1996) An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 24:289–293

    Article  CAS  PubMed  Google Scholar 

  49. Motosugi U, Ichikawa T, Sano K et al (2010) Magnetic resonance elastography of the liver: preliminary results and estimation of inter-rater reliability. Jpn J Radiol 28:623–627

    Article  PubMed  Google Scholar 

  50. Hines CDG, Bley TA, Lindstrom MJ, Reeder SB (2010) Repeatability of magnetic resonance elastography for quantification of hepatic stiffness. J Magn Res Imaging 31:725–731

    Article  Google Scholar 

  51. Shire NJ, Yin M, Chen J et al (2011) Test-retest repeatability of MR elastography for noninvasive liver fibrosis assessment in hepatitis C. J Magn Reson Imaging 34:947–955

    Article  PubMed Central  PubMed  Google Scholar 

  52. Fraquelli M, Rigamonti C, Casazza G et al (2011) Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C. J Hepatol 54:621–628

    Article  PubMed  Google Scholar 

  53. Myers RP, Crotty P, Pomier-Layrargues G, Ma M, Urbanski SJ, Elkashab M (2010) Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy. Liver Int 30:1471–1480

    Article  PubMed  Google Scholar 

  54. Poynard T, Halfon P, Castera L et al (2007) Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin Chem 53:1615–1622

    Article  CAS  PubMed  Google Scholar 

  55. Asbach P, Klatt D, Hamhaber U et al (2008) Assessment of liver viscoelasticity using multifrequency MR elastography. Magn Reson Med 60:373–379

    Article  PubMed  Google Scholar 

  56. Mariappan YK, Venkatesh SK, Glaser KJ, McGee KP, Ehman RL (2013) MR elastography of liver with iron overload: development, evaluation and preliminary clinical experience with improved spin echo and spin echo EPI sequences. Proceedings of the 21st annual meeting of ISMRM, Salt Lake City, 2012 (abstract 985)

Download references

Acknowledgement

We acknowledge the support provided by the Individual Research Grant (IRG 1163/2008) from the National Medical Research Council, Singapore.We would like to thank Dr. Richard L. Ehman and the Buzz group, Mayo Clinic, Rochester, MN, USA for their support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sudhakar Kundapur Venkatesh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Venkatesh, S.K., Wang, G., Lim, S.G. et al. Magnetic resonance elastography for the detection and staging of liver fibrosis in chronic hepatitis B. Eur Radiol 24, 70–78 (2014). https://doi.org/10.1007/s00330-013-2978-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-013-2978-8

Keywords

Navigation